Ophthalmic Sciences - Tel Aviv

Op-Sci is revolutionizing the $7B market for glaucoma management with its groundbreaking AI technology, IOPerfect Visor. Our innovative solution bridges the gap in the market for user-friendly, accurate, and affordable eye pressure tracking - a key biomarker for glaucoma management. Our experienced team, comprised of the world's top glaucoma surgeons, has over seventy years of combined expertise. We have already secured $1.4M USD to reach proof of concept, and we are now looking to raise additional funding to bring our technology to market readiness by 2023. In doing so, we will be able to help 150M people around the world from going blind.